Intranasal Drug Delivery Devices Market by Manufacturers, Types, Regions to 2027Posted by Balaji Deshmukh on March 15th, 2021 Global Intranasal Drug Delivery Devices Market The Global Intranasal Drug Delivery Devices Market size was valued at USD 46.68 billion in 2019 and is projected to expand at a CAGR of 6.7% over the forecast period to reach the valuation of USD 78.43 billion by 2027. Increasing preference for an alternative mode of drug administration is one of the major factors expected to fuel market growth during the forecast period. The growing incidence of chronic diseases is also expected to contribute to intranasal drug delivery devices market expansion over the coming years. According to a study published in Research and Development (RAND) Review blog in 2017, around 60% of American adults have at least one chronic condition, which results in huge spending on healthcare every year. Additionally, nearly 30 million Americans live with five chronic conditions or more. Moreover, the commercialization of innovative products and the presence of a robust product pipeline are anticipated to boost the intranasal drug delivery devices market growth. The report is furnished with the latest market scenario pertaining to the COVID-19 pandemic and its after-effects on the Intranasal Drug Delivery Devices industry and the key segments. The pandemic has disrupted the workflow of the industry and created financial difficulties. The report assesses the complete impact of the pandemic on the market and offers key insights into the market scenario along with trends and demands disruptions. The report also offers an outlook on the market scenario in the forecast timeline. Get a sample of the report @ https://www.reportsanddata.com/toc-form/3570 Some of the players profiled in the report are GlaxoSmithKline PLC; AstraZeneca PLC; Pfizer, Inc.; OptiNose, Inc.; Becton, Dickinson and Company; Promius Pharma, LLC; Cadila Pharmaceuticals Ltd.; B.F. Ascher & Company, Inc.; PendoPharm, Inc.; Douglas Pharmaceuticals Ltd.; ENT Technologies Pty. Ltd.; and NAVEH Pharma Ltd. The Global Intranasal Drug Delivery Devices Market is segmented as follows: By Dosage Form (Revenue, USD Billion, 2017 - 2027) Spray Drops Gel Powder By Container Type (Revenue, USD Billion, 2017 - 2027) Pressurized Non-pressurized By Therapeutic Application (Revenue, USD Billion, 2017 - 2027) Nasal Congestion Rhinitis Asthma Others Market Segmentation by Regions: North America (U.S., Canada) Europe (U.K., Italy, Germany, France, Rest of EU) Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC) Latin America (Chile, Brazil, Argentina, Rest of Latin America) Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA) Key Questions Answered by the Report:
Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or queries about customization options, please reach out to us, and we will offer you the report best suited for your needs. Contact Us: John Watson Head of Business Development Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com Like it? Share it!More by this author |